Literature DB >> 18472276

Theories of carcinogenesis: an emerging perspective.

Carlos Sonnenschein1, Ana M Soto.   

Abstract

Four decades ago Leslie Foulds remarked that "Experimental analysis has produced an alarming mass of empirical facts without providing an adequate language for their communication or effective concepts for their synthesis". Examining the relevance of the data avalanche we all generate and are subjected to in the context of the premises and predictions of the current cancer theories may help resolve this paradox. This goal is becoming increasingly relevant given the looming attempts to rigorously model and parameterize crucial events in carcinogenesis (microenvironmental conditions, cellular proliferation and motility), which will require the adoption of reliable premises on which to base those efforts. This choice must be made a priori, as premises are not testable, and data are not free of the theoretical frame used to gather them. In this review we provide a critical analysis of the two main currents in cancer research, one centered at the cellular level of biological organization, the somatic mutation theory, which conceptualizes carcinogenesis as a problem of cell proliferation control, and the other centered at the tissue level, the tissue organization filed theory, which considers carcinogenesis a process akin to organogenesis gone awry.

Entities:  

Mesh:

Year:  2008        PMID: 18472276      PMCID: PMC2730644          DOI: 10.1016/j.semcancer.2008.03.012

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  54 in total

Review 1.  Regulation of cell proliferation: the negative control perspective.

Authors:  A M Soto; C Sonnenschein
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  Evolution and tinkering.

Authors:  F Jacob
Journal:  Science       Date:  1977-06-10       Impact factor: 47.728

Review 3.  Cell proliferation of estrogen-sensitive cells: the case for negative control.

Authors:  A M Soto; C Sonnenschein
Journal:  Endocr Rev       Date:  1987-02       Impact factor: 19.871

4.  Chemical carcinogenesis: a current biological perspective.

Authors:  E Farber
Journal:  Carcinogenesis       Date:  1984-01       Impact factor: 4.944

Review 5.  From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion.

Authors:  R Kemler
Journal:  Trends Genet       Date:  1993-09       Impact factor: 11.639

6.  The stroma as a crucial target in rat mammary gland carcinogenesis.

Authors:  Maricel V Maffini; Ana M Soto; Janine M Calabro; Angelo A Ucci; Carlos Sonnenschein
Journal:  J Cell Sci       Date:  2004-03-02       Impact factor: 5.285

7.  Genetic resolution of susceptibility to cancer--new perspectives.

Authors:  P Demant
Journal:  Semin Cancer Biol       Date:  1992-06       Impact factor: 15.707

8.  Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts.

Authors:  K Illmensee; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

9.  Defective gap-junctional communication associated with imaginal disc overgrowth and degeneration caused by mutations of the dco gene in Drosophila.

Authors:  V A Jursnich; S E Fraser; L I Held; J Ryerse; P J Bryant
Journal:  Dev Biol       Date:  1990-08       Impact factor: 3.582

Review 10.  Drosophila as a model system for molecular analysis of tumorigenesis.

Authors:  B M Mechler; D Strand; A Kalmes; R Merz; M Schmidt; I Török
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

View more
  56 in total

1.  Fractal analysis in a systems biology approach to cancer.

Authors:  M Bizzarri; A Giuliani; A Cucina; F D'Anselmi; A M Soto; C Sonnenschein
Journal:  Semin Cancer Biol       Date:  2011-04-13       Impact factor: 15.707

Review 2.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

3.  Research on early-stage carcinogenesis: are we approaching paradigm instability?

Authors:  Stuart G Baker; Antonio Cappuccio; John D Potter
Journal:  J Clin Oncol       Date:  2010-06-14       Impact factor: 44.544

4.  Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival.

Authors:  Chun Chao; Lanfang Xu; Michael J Silverberg; Otoniel Martínez-Maza; Lie-Hong Chen; Brandon Castor; Donald I Abrams; Hongbin D Zha; Reina Haque; Jonathan Said
Journal:  AIDS       Date:  2015-09-24       Impact factor: 4.177

Review 5.  Carcinogenesis explained within the context of a theory of organisms.

Authors:  Carlos Sonnenschein; Ana M Soto
Journal:  Prog Biophys Mol Biol       Date:  2016-08-03       Impact factor: 3.667

6.  Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells involves potential organ-specific genes.

Authors:  Laura E Pascal; Young Ah Goo; Ricardo Zn Vêncio; Laura S Page; Amber A Chambers; Emily S Liebeskind; Thomas K Takayama; Lawrence D True; Alvin Y Liu
Journal:  BMC Cancer       Date:  2009-09-08       Impact factor: 4.430

7.  Principles of modular tumor therapy.

Authors:  Albrecht Reichle; Gerhard C Hildebrandt
Journal:  Cancer Microenviron       Date:  2009-07-11

8.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

9.  Improving the biomarker pipeline to develop and evaluate cancer screening tests.

Authors:  Stuart G Baker
Journal:  J Natl Cancer Inst       Date:  2009-07-02       Impact factor: 13.506

10.  Systems biology and cancer prevention: all options on the table.

Authors:  Simon Rosenfeld; Izet Kapetanovic
Journal:  Gene Regul Syst Bio       Date:  2008-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.